Related Experiment Video
Updated: Aug 9, 2025

06:05
An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model
Published on: March 9, 2022
3.9K
Currently available therapies in mitochondrial disease
Cornelia Kornblum1, Costanza Lamperti2, Sumit Parikh3
1Department of Neurology, Neuromuscular Disease Section, University Hospital Bonn, Bonn, Germany.
Handbook of Clinical Neurology
|February 22, 2023
Summary
Mitochondrial diseases are complex genetic disorders affecting multiple organs. Current management focuses on supportive care, supplements, and avoiding toxic medications, as effective treatments are limited.
Area of Science:
- Biochemistry
- Genetics
- Metabolic Disorders
Background:
- Mitochondrial diseases are a diverse group of inherited disorders impacting cellular energy production.
- These conditions affect any organ system, particularly those with high aerobic metabolism, leading to significant morbidity.
- Diagnosis and management are challenging due to genetic heterogeneity and varied clinical presentations.
Approach:
- Reviewing current literature on dietary supplements with some clinical research support for mitochondrial disorders.
- Summarizing recommendations for safe medication use in patients with mitochondrial diseases.
- Discussing management strategies for exercise intolerance and fatigue, including physical training.
Key Points:
- No definitive cure or effective treatment currently exists for most mitochondrial diseases.
- Dietary supplements are commonly used, but robust evidence from randomized controlled trials is scarce.
- Avoiding metabolic decompensation triggers and potentially toxic medications is crucial for patient care.
- Exercise intolerance and fatigue are common debilitating symptoms requiring specific management approaches.
Conclusions:
- Current management of mitochondrial diseases relies on supportive care, symptom management, and preventive strategies.
- Further research is needed to develop specific interventional therapies and validate supplement efficacy.
- Personalized approaches considering genetic defects and clinical manifestations are essential for optimal patient outcomes.
Related Concept Videos
Electron Transport Chain: Complex I and II
14.7K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.7K
ATP Synthase: Mechanism
14.9K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
14.9K
Mitochondrial Membranes
11.7K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
11.7K
Animal Mitochondrial Genetics
7.7K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
7.7K

